Phesi launches AI-driven trial accelerator, saving $7m per t...

Yesterday, global provider of patient-centric data analytics, Phesi launched its AI-driven Trial Accelerator Platform, an

Battling breast cancer with precision medicine

Key operational considerations to optimise decentralised cli...

Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience with decentralised trials, it is appropriate to reflect and ask whether DCT studies are truly

Commercialization of novel gene-editing technology in beta-t...

Gene therapies and research into them have grown immensely in recent years, offering more novel tools in regenerative medicine to fight disease, including rare diseases and genetic disorders.

The Role of Social Media in Healthcare

Why Channel, Content, & Credibility are Key